1 |
Olivera, A., Dillahunt, S. E. and Rivera, J. (2013) Interrogation of sphingosine-1-phosphate receptor 2 function in vivo reveals a prominent role in the recovery from IgE and IgG-mediated anaphylaxis with minimal effect on its onset. Immunol. Lett. 150, 89-96.
DOI
|
2 |
Oskeritzian, C. A., Price, M. M., Hait, N. C., Kapitonov, D., Falanga, Y. T., Morales, J. K., Ryan, J. J., Milstien, S. and Spiegel, S. (2010) Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J. Exp. Med. 207, 465-474.
DOI
|
3 |
Park, S. J. and Im, D. S. (2017) Sphingosine 1-phosphate receptor modulators and drug discovery. Biomol. Ther. (Seoul) 25, 80-90.
DOI
|
4 |
Park, S. J. and Im, D. S. (2019a) Blockage of sphingosine-1-phosphate receptor 2 attenuates allergic asthma in mice. Br. J. Pharmacol. 176, 938-949.
DOI
|
5 |
Park, S. J. and Im, D. S. (2019b) Deficiency of sphingosine-1-phosphate receptor 2 (S1P2) attenuates bleomycin-induced pulmonary fibrosis. Biomol. Ther. (Seoul) 27, 318-326.
DOI
|
6 |
Prieschl, E. E., Csonga, R., Novotny, V., Kikuchi, G. E. and Baumruker, T. (1999) The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering. J. Exp. Med. 190, 1-8.
DOI
|
7 |
Proia, R. L. and Hla, T. (2015) Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. J. Clin. Invest. 125, 1379-1387.
DOI
|
8 |
Reines, I., Kietzmann, M., Mischke, R., Tschernig, T., Luth, A., Kleuser, B. and Baumer, W. (2009) Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration. J. Invest. Dermatol. 129, 1954-1962.
DOI
|
9 |
Bock, S., Pfalzgraff, A. and Weindl, G. (2016) Sphingosine 1-phospate differentially modulates maturation and function of human Langerhans-like cells. J. Dermatol. Sci. 82, 9-17.
DOI
|
10 |
Baumer, W., Rossbach, K., Mischke, R., Reines, I., Langbein-Detsch, I., Luth, A. and Kleuser, B. (2011) Decreased concentration and enhanced metabolism of sphingosine-1-phosphate in lesional skin of dogs with atopic dermatitis: disturbed sphingosine-1-phosphate homeostasis in atopic dermatitis. J. Invest. Dermatol. 131, 266-268.
DOI
|
11 |
Checa, A., Xu, N., Sar, D. G., Haeggstrom, J. Z., Stahle, M. and Wheelock, C. E. (2015) Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-a treatment. Sci. Rep. 5, 12017.
DOI
|
12 |
Japtok, L., Schaper, K., Baumer, W., Radeke, H. H., Jeong, S. K. and Kleuser, B. (2012) Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype. PLoS ONE 7, e49427.
DOI
|
13 |
Jeong, S. K., Kim, Y. I., Shin, K. O., Kim, B. W., Lee, S. H., Jeon, J. E., Kim, H. J., Lee, Y. M., Mauro, T. M., Elias, P. M., Uchida, Y. and Park, K. (2015) Sphingosine kinase 1 activation enhances epidermal innate immunity through sphingosine-1-phosphate stimulation of cathelicidin production. J. Dermatol. Sci. 79, 229-234.
DOI
|
14 |
Tsuji, T., Yoshida, Y., Iwatsuki, R., Inoue, M., Fujita, T. and Kohno, T. (2012) Therapeutic approach to steroid-resistant dermatitis using novel immunomodulator FTY720 (Fingolimod) in combination with betamethasone ointment in NC/Nga mice. Biol. Pharm. Bull. 35, 1314-1319.
DOI
|
15 |
Schaper, K., Dickhaut, J., Japtok, L., Kietzmann, M., Mischke, R., Kleuser, B. and Baumer, W. (2013) Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. J. Dermatol. Sci. 71, 29-36.
DOI
|
16 |
Spiegel, S. and Milstien, S. (2007) Functions of the multifaceted family of sphingosine kinases and some close relatives. J. Biol. Chem. 282, 2125-2129.
DOI
|
17 |
Tsuji, T., Okuno, S., Kuroda, A., Hamazaki, J., Chikami, T., Sakurai, S., Yoshida, Y., Banno, R., Fujita, T. and Kohno, T. (2016) Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice. Allergol. Int. 65, 172-179.
DOI
|
18 |
Yanagawa, Y., Hoshino, Y., Kataoka, H., Kawaguchi, T., Ohtsuki, M., Sugahara, K. and Chiba, K. (1999) FTY720, a novel immunosuppressant, prolongs rat skin allograft survival by decreasing T-cell infiltration into grafts. Transplant. Proc. 31, 1227-1229.
DOI
|
19 |
Kim, D. S., Kim, S. Y., Kleuser, B., Schafer-Korting, M., Kim, K. H. and Park, K. C. (2004) Sphingosine-1-phosphate inhibits human keratinocyte proliferation via Akt/protein kinase B inactivation. Cell. Signal. 16, 89-95.
DOI
|
20 |
Kim, J. Y., Jeong, M. S., Park, M. K., Lee, M. K. and Seo, S. J. (2014) Time-dependent progression from the acute to chronic phases in atopic dermatitis induced by epicutaneous allergen stimulation in NC/Nga mice. Exp. Dermatol. 23, 53-57.
DOI
|
21 |
Muraro, A., Lemanske, R. F., Jr., Hellings, P. W., Akdis, C. A., Bieber, T., Casale, T. B., Jutel, M., Ong, P. Y., Poulsen, L. K., Schmid-Grendelmeier, P., Simon, H. U., Seys, S. F. and Agache, I. (2016) Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J. Allergy Clin. Immunol. 137, 1347-1358.
DOI
|
22 |
Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M. and Tokura, Y. (2008) Possible pathogenic role of Th17 cells for atopic dermatitis. J. Invest. Dermatol. 128, 2625-2630.
DOI
|
23 |
Kohno, T., Tsuji, T., Hirayama, K., Watabe, K., Matsumoto, A., Kohno, T. and Fujita, T. (2004) A novel immunomodulator, FTY720, prevents spontaneous dermatitis in NC/Nga mice. Biol. Pharm. Bull. 27, 1392-1396.
DOI
|
24 |
Leong, W. I. and Saba, J. D. (2010) S1P metabolism in cancer and other pathological conditions. Biochimie 92, 716-723.
DOI
|
25 |
Mysliwiec, H., Baran, A., Harasim-Symbor, E., Choromanska, B., Mysliwiec, P., Milewska, A. J., Chabowski, A. and Flisiak, I. (2017) Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients. Arch. Dermatol. Res. 309, 79-86.
DOI
|
26 |
Nakashima, D., Kabashima, K., Sakabe, J., Sugita, K., Kobayashi, T., Yoshiki, R. and Tokura, Y. (2008) Impaired initiation of contact hypersensitivity by FTY720. J. Invest. Dermatol. 128, 2833-2841.
DOI
|